• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估实验室性能。历史与政府视角。

Evaluating laboratory performance. Historical and governmental perspectives.

作者信息

Boone D J

机构信息

Division of Assessment and Management Consultation, Centers for Disease Control, Atlanta, GA 30333.

出版信息

Arch Pathol Lab Med. 1988 Apr;112(4):354-6.

PMID:3355332
Abstract

Historically, the quality of laboratory performance that must be provided to adequately support medical decision-making has been defined in three major ways: by the analytical variance of the state of the practice; by the total variance, including the expected analytical and biological variability; and by medical-usefulness criteria. Quality goals defined by these approaches have influenced instrument manufacturers, professional societies, governmental agencies, and even the precision and accuracy of medical practice. Despite past efforts, a consensus has not emerged on a scientifically and medically supportable set of laboratory performance requirements. Medically relevant goals for analytic performance would help avoid costly and unnecessary regulatory requirements and permit steady improvement in instrumentation and methods.

摘要

从历史上看,为充分支持医疗决策而必须提供的实验室检测性能质量主要通过三种方式来定义:根据实际操作状态的分析方差;根据总方差,包括预期的分析和生物变异性;以及根据医学实用性标准。这些方法所定义的质量目标已经影响了仪器制造商、专业协会、政府机构,甚至医疗实践的精度和准确性。尽管过去做出了努力,但尚未就一套科学和医学上可支持的实验室检测性能要求达成共识。分析性能的医学相关目标将有助于避免代价高昂且不必要的监管要求,并使仪器和方法得以稳步改进。

相似文献

1
Evaluating laboratory performance. Historical and governmental perspectives.评估实验室性能。历史与政府视角。
Arch Pathol Lab Med. 1988 Apr;112(4):354-6.
2
Federal regulation of clinical laboratories. A prospective public policy analysis.
Arch Pathol Lab Med. 1988 Apr;112(4):363-7.
3
College of American Pathologists Conference XIII on the evaluation of proficiency testing results for quantitative methods in relation to clinical usefulness: concluding remarks.美国病理学家学会关于定量方法能力验证结果与临床实用性评估的第十三次会议:总结发言。
Arch Pathol Lab Med. 1988 Apr;112(4):471-2.
4
The overall role of a proficiency testing program.能力验证计划的整体作用。
Arch Pathol Lab Med. 1988 Apr;112(4):340-2.
5
Internal quality control, proficiency testing, and the clinical relevance of laboratory testing.内部质量控制、能力验证以及实验室检测的临床相关性。
Arch Pathol Lab Med. 1988 Apr;112(4):449-53.
6
The application of theoretical goals based on biological variation data in proficiency testing.
Arch Pathol Lab Med. 1988 Apr;112(4):404-15.
7
An evaluation of the ability of proficiency testing programs to determine intralaboratory performance. Peer group statistics vs clinical usefulness limits.
Arch Pathol Lab Med. 1988 Apr;112(4):444-8.
8
The Medicare and Clinical Laboratories Improvement Act of 1967 proficiency testing requirements and its relationship to the private sector.
Arch Pathol Lab Med. 1988 Apr;112(4):357-62.
9
Governmental perspectives on evaluating laboratory performance.
Clin Chem. 1993 Jul;39(7):1461-5; discussion 1466-7.
10
Proficiency testing programs--promises, progress, and problems. A 40-year prospective.
Arch Pathol Lab Med. 1988 Apr;112(4):329-33.

引用本文的文献

1
Types and frequency of preanalytical mistakes in the first Thai ISO 9002:1994 certified clinical laboratory, a 6 - month monitoring.泰国首家获得ISO 9002:1994认证的临床实验室的分析前错误类型及发生率:为期6个月的监测
BMC Clin Pathol. 2001;1(1):5. doi: 10.1186/1472-6890-1-5.
2
Evolving approaches to management of quality in clinical microbiology.临床微生物学质量控制的不断发展的管理方法。
Clin Microbiol Rev. 1994 Jan;7(1):55-88. doi: 10.1128/CMR.7.1.55.